Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

427799

registered interest
date	10/11/2015
answering body	Ministry of Justice
answering dept id	54
answering dept short name	Justice
answering dept sort name	Justice
hansard heading	Prisoners' Release
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Justice, how many people have been (a) murdered, (b) assaulted and (c) subject to a violent crime committed by people released from prison on licence in (i) England and (ii) Wales in each of the last five years.
tabling member constituency	Aberconwy
tabling member printed	Guto Bebb
uin	15823
answer	answer is ministerial correction date of answer 23/11/2015 answer text <p>Offenders on licence are subject to strict controls and may be recalled to custody if they breach their licence conditions. Offender managers regularly review the risk presented by offenders and may place additional controls where they are needed to protect the public.</p><p>The latest data on the number of offenders who were convicted of a Serious Further Offence of Murder are published in Annex B of Proven reoffending statistics January 2013 to December 2013, published at <a href="https://www.gov.uk/government/statistics/proven-reoffending-statistics-january-2013-to-december-2013" target="_blank">https://www.gov.uk/government/statistics/proven-reoffending-statistics-january-2013-to-december-2013</a>. The published figures include all offenders under any form of probation supervision, rather than just those on licence.</p><p>The information requested is set out in the table below, based on data collected under the Probation Serious Further Offence (SFO) Review Procedures. The figure for the most recent year does not include cases where an offender has been charged with but not yet convicted of murder.</p><br /><table><tbody><tr><td><p>Date</p></td><td><p>01/11/2010 – 31/10/2011</p></td><td><p>01/11/2011 – 31/10/2012</p></td><td><p>01/11/2012 – 31/10/2013</p></td><td><p>01/11/2013 – 31/10/2014</p></td><td><p>01/11/2014 – 31/10/2015</p></td></tr><tr><td><p>No of Murders</p></td><td colspan="5"><p><br></p></td></tr><tr><td><p>England</p></td><td><p>23</p></td><td><p>20</p></td><td><p>25</p></td><td><p>21</p></td><td><p>6</p></td></tr><tr><td><p>Wales</p></td><td><p>2</p></td><td><p>0</p></td><td><p>1</p></td><td><p>2</p></td><td><p>0</p></td></tr></tbody></table><br /><p>The offences of violence against the person or violent crime in such general form do not fall in scope of the Probation SFO Review Procedures. Data on offenders released on a licence who have committed offences other than those in scope of the SFO Review Procedures are not held centrally in a readily accessible format for the last five years. To obtain these data would incur disproportionate costs.</p> answering member constituency South West Bedfordshire answering member printed Andrew Selous question first answered 23/11/2015 16:52:54 answering member 1453 label Biography information for Andrew Selous
tabling member	3910 label Biography information for Guto Bebb

425126

registered interest
date	30/10/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prostate Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what representations he has received on the availability of comparative information on and screening for prostate cancer.
tabling member constituency	Aberconwy
tabling member printed	Guto Bebb
uin	14175
answer	answer is ministerial correction date of answer 16/11/2015 answer text <p>The UK National Screening Committee (UK NSC) advises Ministers and the National Health Service in all four countries about all aspects of screening policy and supports implementation. In 2010, the UK NSC recommended against a screening programme for prostate cancer as there was no clear evidence that the benefit to screen for prostate cancer outweighed the harms. The UK NSC re-affirmed this decision in 2012 and is in the process of reviewing this policy currently.</p><br /><p>The School of Health and Related Research at the University of Sheffield performed an option appraisal for the UK NSC based on the latest trial evidence for screening for prostate cancer in 2013. A number of screening strategies were considered including annual screening in men aged 50 to 74 years. The overall survival benefit with all strategies was small and outweighed by the harms of over diagnosis and the adverse effects of over treatment.</p><br /><p>Public Health England (PHE) ran a local pilot campaign for six weeks in 2014, specifically targeting prostate cancer within Black African-Caribbean men, because of their significantly increased risk of developing prostate cancer. The campaign ran in six London boroughs. In addition, PHE will be running a national campaign on “Blood in Pee” in early 2016. This is primarily aimed at bladder and kidney cancer but blood in the urine can also be a sign of prostate cancer.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 14176 14177 14178 question first answered 16/11/2015 17:46:18 answering member 3918 label Biography information for Jane Ellison
tabling member	3910 label Biography information for Guto Bebb

425128

registered interest
date	30/10/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prostate Cancer: Health Education
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department has taken to increase awareness of prostate cancer.
tabling member constituency	Aberconwy
tabling member printed	Guto Bebb
uin	14178
answer	answer is ministerial correction date of answer 16/11/2015 answer text <p>The UK National Screening Committee (UK NSC) advises Ministers and the National Health Service in all four countries about all aspects of screening policy and supports implementation. In 2010, the UK NSC recommended against a screening programme for prostate cancer as there was no clear evidence that the benefit to screen for prostate cancer outweighed the harms. The UK NSC re-affirmed this decision in 2012 and is in the process of reviewing this policy currently.</p><br /><p>The School of Health and Related Research at the University of Sheffield performed an option appraisal for the UK NSC based on the latest trial evidence for screening for prostate cancer in 2013. A number of screening strategies were considered including annual screening in men aged 50 to 74 years. The overall survival benefit with all strategies was small and outweighed by the harms of over diagnosis and the adverse effects of over treatment.</p><br /><p>Public Health England (PHE) ran a local pilot campaign for six weeks in 2014, specifically targeting prostate cancer within Black African-Caribbean men, because of their significantly increased risk of developing prostate cancer. The campaign ran in six London boroughs. In addition, PHE will be running a national campaign on “Blood in Pee” in early 2016. This is primarily aimed at bladder and kidney cancer but blood in the urine can also be a sign of prostate cancer.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 14175 14176 14177 question first answered 16/11/2015 17:46:18 answering member 3918 label Biography information for Jane Ellison
tabling member	3910 label Biography information for Guto Bebb

425129

registered interest
date	30/10/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prostate Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of an annual screening programme on early detection of prostate cancer.
tabling member constituency	Aberconwy
tabling member printed	Guto Bebb
uin	14176
answer	answer is ministerial correction date of answer 16/11/2015 answer text <p>The UK National Screening Committee (UK NSC) advises Ministers and the National Health Service in all four countries about all aspects of screening policy and supports implementation. In 2010, the UK NSC recommended against a screening programme for prostate cancer as there was no clear evidence that the benefit to screen for prostate cancer outweighed the harms. The UK NSC re-affirmed this decision in 2012 and is in the process of reviewing this policy currently.</p><br /><p>The School of Health and Related Research at the University of Sheffield performed an option appraisal for the UK NSC based on the latest trial evidence for screening for prostate cancer in 2013. A number of screening strategies were considered including annual screening in men aged 50 to 74 years. The overall survival benefit with all strategies was small and outweighed by the harms of over diagnosis and the adverse effects of over treatment.</p><br /><p>Public Health England (PHE) ran a local pilot campaign for six weeks in 2014, specifically targeting prostate cancer within Black African-Caribbean men, because of their significantly increased risk of developing prostate cancer. The campaign ran in six London boroughs. In addition, PHE will be running a national campaign on “Blood in Pee” in early 2016. This is primarily aimed at bladder and kidney cancer but blood in the urine can also be a sign of prostate cancer.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 14175 14177 14178 question first answered 16/11/2015 17:46:18 answering member 3918 label Biography information for Jane Ellison
tabling member	3910 label Biography information for Guto Bebb

425130

registered interest
date	30/10/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prostate Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department has taken to support prostate cancer awareness campaigns and screening programmes.
tabling member constituency	Aberconwy
tabling member printed	Guto Bebb
uin	14177
answer	answer is ministerial correction date of answer 16/11/2015 answer text <p>The UK National Screening Committee (UK NSC) advises Ministers and the National Health Service in all four countries about all aspects of screening policy and supports implementation. In 2010, the UK NSC recommended against a screening programme for prostate cancer as there was no clear evidence that the benefit to screen for prostate cancer outweighed the harms. The UK NSC re-affirmed this decision in 2012 and is in the process of reviewing this policy currently.</p><br /><p>The School of Health and Related Research at the University of Sheffield performed an option appraisal for the UK NSC based on the latest trial evidence for screening for prostate cancer in 2013. A number of screening strategies were considered including annual screening in men aged 50 to 74 years. The overall survival benefit with all strategies was small and outweighed by the harms of over diagnosis and the adverse effects of over treatment.</p><br /><p>Public Health England (PHE) ran a local pilot campaign for six weeks in 2014, specifically targeting prostate cancer within Black African-Caribbean men, because of their significantly increased risk of developing prostate cancer. The campaign ran in six London boroughs. In addition, PHE will be running a national campaign on “Blood in Pee” in early 2016. This is primarily aimed at bladder and kidney cancer but blood in the urine can also be a sign of prostate cancer.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 14175 14176 14178 question first answered 16/11/2015 17:46:18 answering member 3918 label Biography information for Jane Ellison
tabling member	3910 label Biography information for Guto Bebb

422620

registered interest
date	20/10/2015
answering body	Foreign and Commonwealth Office
answering dept id	16
answering dept short name	Foreign and Commonwealth Office
answering dept sort name	Foreign and Commonwealth Office
hansard heading	Israel: Palestinians
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Foreign and Commonwealth Affairs, what reports he has received on the involvement of Palestinian terror groups in the recent violence in Israel and the West Bank.
tabling member constituency	Aberconwy
tabling member printed	Guto Bebb
uin	12633
answer	answer is ministerial correction date of answer 28/10/2015 answer text <p>While it appears that the majority of the attacks seen in Israel and the Occupied Palestinian Territories in recent weeks have been carried out by individuals, without direct organisation from political or terrorist groups, we have seen media reports of Palestinian terrorist groups claiming responsibility for some recent attacks, praising attacks, and appearing to incite further violence. We condemn all the terrorist attacks, as I made clear in the House on 20 October, and in my statement on 13 October.</p> answering member constituency Bournemouth East answering member printed Mr Tobias Ellwood question first answered 28/10/2015 09:40:12 answering member 1487 label Biography information for Mr Tobias Ellwood
tabling member	3910 label Biography information for Guto Bebb

419848

registered interest
date	09/10/2015
answering body	HM Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	CaTreasury
hansard heading	Small Businesses: VAT
house id	1
legislature	25259 pref label House of Commons
question text	To ask Mr Chancellor of the Exchequer, what assessment his Department has made of the effect on SMEs of a move from the flat rate scheme for VAT to the general rate.
tabling member constituency	Aberconwy
tabling member printed	Guto Bebb
uin	10891
answer	answer is ministerial correction date of answer 21/10/2015 answer text <p>HMRC estimates that, on average, businesses moving from the flat rate scheme to standard VAT accounting incur extra administrative costs of £45 per year.</p> answering member constituency South West Hertfordshire answering member printed Mr David Gauke question first answered 21/10/2015 13:30:18 answering member 1529 label Biography information for Mr David Gauke
tabling member	3910 label Biography information for Guto Bebb

419849

registered interest
date	09/10/2015
answering body	HM Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	CaTreasury
hansard heading	Tourism: VAT
house id	1
legislature	25259 pref label House of Commons
question text	To ask Mr Chancellor of the Exchequer, whether his Department has made an assessment of the potential benefits of increasing the turnover threshold at which it becomes necessary to adopt the general rate for VAT for the tourism industry.
tabling member constituency	Aberconwy
tabling member printed	Guto Bebb
uin	10892
answer	answer is ministerial correction date of answer 20/10/2015 answer text <p>No such assessment has been made. The Government has chosen to maintain the highest VAT registration threshold in the EU. EU law allows us to increase the threshold in line with inflation, and it has therefore increased to £82,000 with effect from 1 April 2015.</p> answering member constituency South West Hertfordshire answering member printed Mr David Gauke question first answered 20/10/2015 16:36:42 answering member 1529 label Biography information for Mr David Gauke
tabling member	3910 label Biography information for Guto Bebb

419862

registered interest
date	09/10/2015
answering body	HM Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	CaTreasury
hansard heading	Small Businesses: Loans
house id	1
legislature	25259 pref label House of Commons
question text	To ask Mr Chancellor of the Exchequer, when he plans to respond to the recommendations of the Treasury Committee's report, Conduct and competition in SME lending, published on 16 March 2015.
tabling member constituency	Aberconwy
tabling member printed	Guto Bebb
uin	11212
answer	answer is ministerial correction date of answer 29/10/2015 answer text <p>The Parliament, and its then Treasury Select Committee, dissolved shortly after this report was published and HM Treasury was not able to prepare a response before dissolution.</p><br /><p>HM Treasury is considering the Committee’s recommendations and will be responding to the new Committee in due course.</p> answering member constituency West Worcestershire answering member printed Harriett Baldwin grouped question UIN 10920 question first answered 29/10/2015 15:16:54 answering member 4107 label Biography information for Dame Harriett Baldwin
tabling member	3910 label Biography information for Guto Bebb

419548

registered interest
date	17/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Nivolumab
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, pursuant to the Answer of 14 September 2015 to Question 8491, whether interim commissioning arrangements are being considered for nivolumab lung cancer.
tabling member constituency	Aberconwy
tabling member printed	Guto Bebb
uin	10596
answer	answer is ministerial correction date of answer 14/10/2015 answer text <p>NHS England is aware that the National Institute for Health and Care Excellence is reviewing the use of nivolumab in lung cancer, and is likely to report shortly. NHS England has therefore advised that it intends to await the NICE recommendation rather than develop interim arrangements.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 14/10/2015 10:42:09 answering member 4020 label Biography information for George Freeman
tabling member	3910 label Biography information for Guto Bebb